Welcome to the June edition of our restructuring and insolvency bulletin. With the cost-of-living crisis ongoing, many holidays thwarted by overwhelmed airlines, and the party-gate scandal going strong, the recent Jubilee weekend brought a refreshing change...
1 May marks the start of our new financial year, and with the new year comes new beginnings and fond farewells. Many of you will already be aware that after 20 years with Stevens & Bolton, Jonathan Porteous has stepped down as partner and head of the...
1 May marks the start of our new financial year, and with the new year comes new beginnings and fond farewells. After 20 years with Stevens & Bolton, Jonathan Porteous has stepped down as partner and head of the finance, restructuring and insolvency...
Welcome to our latest edition of the commercial and technology update. This edition features key insights and updates from our commercial team across a range of legal sectors including contracts, data protection, technology, retail and regulatory. To...
As the days draw out and the clocks ‘spring forward’, there is optimism in the air. However, with the UK suffering the highest rate of inflation for 30 years, energy prices sky-rocketing and interest rates rising for the third time in four...
In this update, we take a look at a landmark High Court decision on the conduct of clinical trials, plus we consider two new consultations on the protection of health data. We also bring you the last entry in our Life Sciences Legal A to Z. In case you...
Happy lunar new year to our clients and readers and welcome to our first banking and finance newsletter of 2022! We hope you had a restful Christmas period and successfully managed to dodge the dreaded C-word, and have made it through the bleakest month of...
Happy lunar new year to our clients and readers and congratulations to everybody who has made it to the end of veganuary, dry January and any other similarly worthy New Year's resolution. While many spend January in hibernation, recovering from a...
In this update, we consider the impact on parallel trade following the introduction of additional safety features for medicine packaging under the EU Falsified Medicines Directive, plus we discuss the requirement for establishment in the UK following Brexit....
Welcome to our latest edition of the commercial and technology update. This edition features key insights and updates from our commercial team across a range of legal sectors including contracts, data protection, competition, technology, retail and...
Welcome to the first edition of our restructuring and insolvency bulletin for 2022. Happy New Year to our clients and readers! We hope you are all weathering the Omicron storm and managed to enjoy the festive break. Here’s hoping this is the last...
The clock is ticking for the new National Security and Investment Act 2021 (the NSI Act) which comes into force on 4 January 2022. Are you ready? To remind yourself of the impact of the NSI Act on the life sciences industry read our summary below. We also...
We bring you our round-up of the latest IP issues that matter. A link to the web version of this email update is available here . If you would like to receive these updates via email, please subscribe . READ THE WEB VERSION ...
Providing an update and guidance on the latest key legal issues affecting employers. A link to the web version of this email update is available here . If you would like to receive these updates via email, please subscribe . READ THE WEB...
In this update, we consider the judicial review process in the context of challenging NICE guidelines. In the latest entries to our Life Sciences Legal A to Z, we also explain the concepts of Ex Parte and, separately, Ex Works. In case you missed it, the...
Search our site